72 related articles for article (PubMed ID: 23303387)
21. Identification of miRSNPs associated with the risk of multiple myeloma.
Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
[TBL] [Abstract][Full Text] [Related]
22. Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
Lincz LF; Scorgie FE; Robertson R; Enno A
Leuk Res; 2007 Jun; 31(6):759-63. PubMed ID: 16949155
[TBL] [Abstract][Full Text] [Related]
23. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
[TBL] [Abstract][Full Text] [Related]
24. Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR).
Echchgadda I; Song CS; Oh TS; Cho SH; Rivera OJ; Chatterjee B
Mech Ageing Dev; 2004; 125(10-11):733-45. PubMed ID: 15541768
[TBL] [Abstract][Full Text] [Related]
25. Cell-based systems to assess nuclear receptor activation and their use in drug development.
Raucy JL; Lasker JM
Drug Metab Rev; 2013 Feb; 45(1):101-9. PubMed ID: 23330544
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
Ríos R; Lupiañez CB; Campa D; Martino A; Martínez-López J; Martínez-Bueno M; Varkonyi J; García-Sanz R; Jamroziak K; Dumontet C; Cayuela AJ; Wętek M; Landi S; Rossi AM; Lesueur F; Reis RM; Moreno V; Marques H; Jurczyszyn A; Andersen V; Vogel U; Buda G; Orciuolo E; Jacobsen SE; Petrini M; Vangsted AJ; Gemignani F; Canzian F; Jurado M; Sainz J
Endocr Relat Cancer; 2015 Aug; 22(4):545-59. PubMed ID: 26099684
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Chew SC; Lim J; Singh O; Chen X; Tan EH; Lee EJ; Chowbay B
Eur J Clin Pharmacol; 2014 Feb; 70(2):155-66. PubMed ID: 24193570
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Campa D; Martino A; Sainz J; Buda G; Jamroziak K; Weinhold N; Vieira Reis RM; García-Sanz R; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Lesueur F; Bugert P; Moreno V; Szemraj J; Orciuolo E; Gemignani F; Rossi AM; Dumontet C; Petrini M; Goldschmidt H; Landi S; Canzian F
Br J Haematol; 2012 May; 157(3):331-8. PubMed ID: 22590720
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
Birmann BM; Tamimi RM; Giovannucci E; Rosner B; Hunter DJ; Kraft P; Mitsiades C; Anderson KC; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):282-8. PubMed ID: 19124510
[TBL] [Abstract][Full Text] [Related]
30. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.
Ríos-Tamayo R; Lupiañez CB; Campa D; Hielscher T; Weinhold N; Martínez-López J; Jerez A; Landi S; Jamroziak K; Dumontet C; Wątek M; Lesueur F; Reis RM; Marques H; Jurczyszyn A; Vogel U; Buda G; García-Sanz R; Orciuolo E; Petrini M; Vangsted AJ; Gemignani F; Försti A; Goldschmidt H; Hemminki K; Canzian F; Jurado M; Sainz J
Oncotarget; 2016 Sep; 7(37):59029-59048. PubMed ID: 27437873
[TBL] [Abstract][Full Text] [Related]
31. PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population.
Lima LO; Almeida S; Hutz MH; Fiegenbaum M
Mol Biol Rep; 2013 Feb; 40(2):1241-7. PubMed ID: 23079705
[TBL] [Abstract][Full Text] [Related]
32. Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.
Lee KM; Baris D; Zhang Y; Hosgood HD; Menashe I; Yeager M; Zahm SH; Wang SS; Purdue MP; Chanock S; Zheng T; Rothman N; Lan Q
Am J Hematol; 2010 Aug; 85(8):560-3. PubMed ID: 20568250
[TBL] [Abstract][Full Text] [Related]
33. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Macauda A; Clay-Gilmour A; Hielscher T; Hildebrandt MAT; Kruszewski M; Orlowski RZ; Kumar SK; Ziv E; Orciuolo E; Brown EE; Försti A; Waller RG; Machiela MJ; Chanock SJ; Camp NJ; Rymko M; Raźny M; Cozen W; Várkonyi J; Piredda C; Pelosini M; Belachew AA; Subocz E; Hemminki K; Rybicka-Ramos M; Giles GG; Milne RL; Hofmann JN; Zaucha JM; Vangsted AJ; Goldschmidt H; Rajkumar SV; Tomczak W; Sainz J; Butrym A; Watek M; Iskierka-Jazdzewska E; Buda G; Robinson DP; Jurczyszyn A; Dudziński M; Martinez-Lopez J; Sinnwell JP; Slager SL; Jamroziak K; Reis RMV; Weinhold N; Bhatti P; Carvajal-Carmona LG; Zawirska D; Norman AD; Mazur G; Berndt SI; Campa D; Vachon CM; Canzian F
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1863-1866. PubMed ID: 35700034
[TBL] [Abstract][Full Text] [Related]
34. Nuclear receptor variants in liver disease.
Zimmer V; Liebe R; Lammert F
Dig Dis; 2015; 33(3):415-9. PubMed ID: 26045277
[TBL] [Abstract][Full Text] [Related]
35. Drug metabolism and clearance system in tumor cells of patients with multiple myeloma.
Hassen W; Kassambara A; Reme T; Sahota S; Seckinger A; Vincent L; Cartron G; Moreaux J; Hose D; Klein B
Oncotarget; 2015 Mar; 6(8):6431-47. PubMed ID: 25669983
[TBL] [Abstract][Full Text] [Related]
36. Lack of association of the pregnane X receptor (PXR/NR1I2) gene with inflammatory bowel disease: parallel allelic association study and gene wide haplotype analysis.
Ho GT; Soranzo N; Tate SK; Drummond H; Nimmo ER; Tenesa A; Arnott ID; Satsangi J
Gut; 2006 Nov; 55(11):1676-7. PubMed ID: 17047126
[No Abstract] [Full Text] [Related]
37. HLA polymorphism and risk of multiple myeloma.
Beksac M; Gragert L; Fingerson S; Maiers M; Zhang MJ; Albrecht M; Zhong X; Cozen W; Dispenzieri A; Lonial S; Hari P
Leukemia; 2016 Nov; 30(11):2260-2264. PubMed ID: 27461064
[No Abstract] [Full Text] [Related]
38. The contribution of
Niebudek K; Balcerczak E; Mirowski M; Pietrzak J; Zawadzka I; Żebrowska-Nawrocka M
Onco Targets Ther; 2019; 12():1655-1660. PubMed ID: 30881020
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma.
Vangsted AJ; Klausen TW; Gimsing P; Abildgaard N; Andersen NF; Gang AO; Holmström M; Gregersen H; Vogel U; Schwarz P; Jørgensen NR
Eur J Haematol; 2014 Aug; 93(2):172-4. PubMed ID: 24766221
[No Abstract] [Full Text] [Related]
40. Variation in innate immunity genes and risk of multiple myeloma.
Purdue MP; Lan Q; Menashe I; Zheng T; Zhang Y; Yeager M; Hosgood HD; Zahm SH; Chanock SJ; Rothman N; Baris D
Hematol Oncol; 2011 Mar; 29(1):42-6. PubMed ID: 20658475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
